Literature DB >> 8663038

Localization of the vinblastine-binding site on beta-tubulin.

S S Rai1, J Wolff.   

Abstract

A fluorescent vinblastine derivative, vinblastine-4'-anthranilate, has been shown to inhibit polymerization of rat brain tubulin (IC50 = 4.8 microM). Binding of the drug to tubulin increases fluorescence intensity, causes a small emission blue shift, and has a quantum yield of 0.037. Fluorescence increases as a function of drug concentration, with a high affinity site and an undetermined number of lower affinity sites. Photolabeling, by exciting the fluorescent drug-tubulin complex at the absorption maximum of anthranilate, yields a covalent adduct confined to beta-tubulin. Its formation is specific in that it is blocked by maytansine or vinblastine. Tryptic hydrolysis identifies a single fluorescent beta-peptide coinciding with residues 175-213. The interactions between various ligands at this central portion of beta-tubulin are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663038     DOI: 10.1074/jbc.271.25.14707

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Nuclear dynamics in Arabidopsis thaliana.

Authors:  E Chytilova; J Macas; E Sliwinska; S M Rafelski; G M Lambert; D W Galbraith
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

Review 2.  Antimicrotubular drugs binding to vinca domain of tubulin.

Authors:  Suvroma Gupta; Bhabatarak Bhattacharyya
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 3.  Potential of plant-derived natural products in the treatment of leukemia and lymphoma.

Authors:  David M Lucas; Patrick C Still; Lynette Bueno Pérez; Michael R Grever; A Douglas Kinghorn
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

4.  Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compounds.

Authors:  Fiona L Henriquez; Paul R Ingram; Stephen P Muench; David W Rice; Craig W Roberts
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

Review 5.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

6.  Hsp70 and thermal pretreatment mitigate developmental damage caused by mitotic poisons in Drosophila.

Authors:  Olga A Isaenko; Timothy L Karr; Martin E Feder
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

7.  The C terminus of beta-tubulin regulates vinblastine-induced tubulin polymerization.

Authors:  S S Rai; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  Characterization of a novel angiogenic model based on stable, fluorescently labelled endothelial cell lines amenable to scale-up for high content screening.

Authors:  Natalie L Prigozhina; Andrew Heisel; Ke Wei; Roberta Noberini; Edward A Hunter; Diego Calzolari; Jordan R Seldeen; Elena B Pasquale; Pilar Ruiz-Lozano; Mark Mercola; Jeffrey H Price
Journal:  Biol Cell       Date:  2011-10-01       Impact factor: 4.458

Review 9.  Targeting microtubules by natural agents for cancer therapy.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

10.  Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.

Authors:  Tetsuya Kokabu; Taisuke Mori; Hiroshi Matsushima; Kaori Yoriki; Hisashi Kataoka; Yosuke Tarumi; Jo Kitawaki
Journal:  Cell Oncol (Dordr)       Date:  2019-01-31       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.